Involvement of Microtubules in the Regulation of Bcl2 Phosphorylation and Apoptosis through Cyclic AMP-Dependent Protein Kinase

REFERENCES

• Blagosklonny, M. V., P. Giannakakou, W. S. El-Deiry, D. G. I. Kingston, P. I. Higgs, L. Neckers, and T. Fojo 1997. Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. Cancer Res. 57: 130–135.
   PubMed Web of Science ®Google Scholar
• Boise, L. H., M. Gonzalez-Garcia, C. E. Postema, L. Ding, T. Lindsten, L. A. Turka, X. Mao, G. Nunez, and C. B. Thompson 1993. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597–608.
   PubMed Web of Science ®Google Scholar
• Boyd, J. M., G. J. Gallo, B. Elangovan, A. B. Houghton, S. Malstrom, B. J. Avery, R. G. Ebb, T. Subramanian, T. Chittenden, R. J. Lutz, and G. Chinnadurai 1995. Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene 11: 1921–1928.
   PubMed Web of Science ®Google Scholar
• Carson, D. A., and J. M. Ribeiro 1993. Apoptosis and disease. Lancet 341: 1251–1254.
   PubMed Web of Science ®Google Scholar
• Cheng, E. H., J. Nicholas, D. S. Bellows, G. S. Hayward, H. G. Guo, M. S. Reitz, and J. M. Hardwick 1997. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc. Natl. Acad. Sci. USA 94: 690–694.
   PubMed Web of Science ®Google Scholar
• Cho-Chung, Y. S. 1990. Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: new approach to therapy. Cancer Res. 50: 7093–7100.
   PubMed Web of Science ®Google Scholar
• Cho-Chung, Y. S., M. Nesterova, A. Kondrashin, K. Noguchi, R. K. Srivastava, and S. Pepe 1997. Antisense-protein kinase A: a single-gene-based therapeutic approach. Antisense Nucleic Acid Drug Dev. 7: 217–223.
   PubMedGoogle Scholar
• Donaldson, K. L., G. L. Goolsby, P. A. Kiener, and A. F. Wahl 1994. Activation of p34cdc2 coincident with taxol-induced apoptosis. Cell Growth Differ. 5: 1041–1050.
   PubMedGoogle Scholar
• Enari, M., H. Hug, and S. Nagata 1995. Involvement of ICE-like protease in Fas-mediated apoptosis. Nature 375: 78–81.
   PubMed Web of Science ®Google Scholar
• Fernandes-Alnemri, T., G. Litwack, and E. S. Alnemri 1994. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian-1β-converting enzyme. J. Biol. Chem. 269: 30761–30764.
   PubMed Web of Science ®Google Scholar
• Haldar, S., A. Basu, and C. M. Croce 1997. Bcl2 is the guardian of microtubule integrity. Cancer Res. 57: 229–233.
   PubMed Web of Science ®Google Scholar
• Haldar, S., J. Chintapalli, and C. M. Croce 1996. Taxol-induced bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res. 56: 1253–1255.
   PubMed Web of Science ®Google Scholar
• Haldar, S., N. Jena, and C. M. Croce 1995. Inactivation of bcl-2 by phosphorylation. Proc. Natl. Acad. Sci. USA 92: 4507–4511.
   PubMed Web of Science ®Google Scholar
• Harrison, D. J. 1995. Molecular mechanism of drug resistance in tumors. J. Pathol. 175: 7–12.
   PubMed Web of Science ®Google Scholar
• Hickman, J. A. 1992. Apoptosis induced by anti-cancer drugs. Cancer Metastasis Res. 11: 121–139.
   PubMed Web of Science ®Google Scholar
• Hockenbery, D. 1995. Defining apoptosis. Am. J. Pathol. 146: 16–19.
   PubMed Web of Science ®Google Scholar
• Horiuchi, M., W. Hayashida, T. Kambe, T. Yamada, and V. J. Dzau 1997. Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis. J. Biol. Chem. 272: 19022–19026.
   PubMed Web of Science ®Google Scholar
• Ito, T., X. Deng, B. Carr, and W. S. May 1997. Bcl-2 phosphorylation required for anti-apoptosis function. J. Biol. Chem. 272: 11671–11673.
   PubMed Web of Science ®Google Scholar
• Kaufmann, S. H., S. Desnoyers, Y. Ottaviano, N. E. Davidson, and G. G. Poirier 1993. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 53: 3976–3985.
   PubMed Web of Science ®Google Scholar
• Krebs, E. G., and J. A. Beavo 1979. Phosphorylation-dephosphorylation of enzymes. Annu. Rev. Biochem. 88: 923–939.
   Google Scholar
• Kroemer, G. 1997. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 3: 614–620.
   PubMed Web of Science ®Google Scholar
• Kumar, N. 1981. Taxol-induced polymerization of purified tubulin. J. Biol. Chem. 256: 10435–10441.
   PubMed Web of Science ®Google Scholar
• Lanotte, M., J. B. Riviere, S. Hermouet, G. Houge, O. K. Wintermyr, B. T. Gjertsen, and S. O. Doskeland 1991. Programmed cell death (apoptosis) is induced rapidly and with positive cooperativity by activation of cyclic adenosine monophosphate-kinase I in a myeloid leukemia cell line. J. Cell Physiol. 146: 73–80.
   PubMed Web of Science ®Google Scholar
• Lazebnik, Y. A., S. H. Kaufmann, S. Desnoyers, G. G. Poirier, and W. C. Earnshaw 1994. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371: 346–347.
   PubMed Web of Science ®Google Scholar
• Martin, S. J., and D. R. Green 1995. Protease activation during apoptosis. Death by a thousand cuts? Cell 82: 349–352.
   PubMed Web of Science ®Google Scholar
• May, W. S., P. G. Tyler, T. Ito, D. K. Armstrong, K. A. Qatsha, and N. E. Davidson 1994. Interleukin-3 and bryostatin-1 mediate hyperphosphorylation of Bcl2α in association with suppression of apoptosis. J. Biol. Chem. 269: 26865–26870.
   PubMed Web of Science ®Google Scholar
• Nagata, S., and P. Golstein 1995. The Fas death factor. Science 267: 1449–1456.
   PubMed Web of Science ®Google Scholar
• Nicholson, D. W., A. Ali, N. A. Thornberry, J. P. Vaillancourt, C. K. Ding, M. Gallant, Y. Gareau, P. R. Griffin, M. Labelle, Y. A. Lazebnik, N. A. Munday, S. M. Raju, M. E. Smulson, Y. Yamin, V. L. Yu, and D. K. Miller 1995. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37–43.
   PubMed Web of Science ®Google Scholar
• Oltvai, Z. N., and S. J. Korsmeyer 1994. Checkpoints of dueling dimers foil death wishes. Cell 79: 189–192.
   PubMed Web of Science ®Google Scholar
• Oltvai, Z. N., C. L. Milliman, and S. J. Korsmeyer 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 74: 609–619.
   PubMed Web of Science ®Google Scholar
• Park, J., I. Kim, Y. U. Oh, K.-W. Lee, H. Pyung-Lim, and E.-J. Choi 1997. Activation of c-Jun N-terminal Kinase antagonizes an antiapoptotic action of Bcl2. J. Biol. Chem. 272: 16725–16728.
   PubMed Web of Science ®Google Scholar
• Pietenpol, J. A., N. Papadopoulos, S. Markowitz, J. K. V. Willson, K. W. Kinzler, and B. Vogelstein 1994. Paradoxical inhibition of solid tumor cell growth by Bcl2. Cancer Res. 54: 3714–3717.
   PubMed Web of Science ®Google Scholar
• Reed, J. C. 1994. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124: 1–6.
   PubMed Web of Science ®Google Scholar
• Sackett, D. I. 1995. Vinca site agents induce structural changes in tubulin different from and antagonistic to changes induced by colchicine site agents. Biochemistry 34: 7010–7019.
   PubMedGoogle Scholar
• Sato, T., M. Hanada, S. Bodrag, S. Irie, N. Iwame, L. H. Boise, C. B. Thompson, S. Colemia, I. Fong, H.-G. Wary, and J. C. Reed 1994. Interaction among members of the bcl-2 protein family analyzed with a yeast two-hybrid system. Proc. Natl. Acad. Sci. USA 91: 9238–9242.
   PubMed Web of Science ®Google Scholar
• Scala, S., A. Budilon, Z. Zhan, Y. S. Cho-Chung, J. Jefferson, M. Tsokos, and S. E. Bates 1995. Downregulation of mdr-1 expression by 8-Cl-cAMP in multidrug resistant MCF-7 human breast cancer cells. J. Clin. Invest. 96: 1026–1034.
   PubMedGoogle Scholar
• Srivastava, R. K., A. R. Srivastava, and Y. S. Cho-Chung 1998. Synergistic effects of 8-Cl-cAMP and retinoic acid on induction of apoptosis in Ewing’s sarcoma CHP-100 cells. Clin. Cancer Res. 4: 755–761.
   PubMedGoogle Scholar
• Tang, C., M. C. Willingam, J. C. Reed, T. Miyashita, S. Ray, V. Ponnatpur, Y. Huang, M. E. Mahoney, G. Bullock, and K. Bhalla 1994. High levels of p26Bcl2 oncoprotein related taxol-induced apoptosis in human pre-B leukemia cells. Leukemia (Baltimore) 8: 1960–1969.
   PubMed Web of Science ®Google Scholar
• Tewari, M., and V. M. Dixit 1995. Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus CrmA gene product. J. Biol. Chem. 270: 3255–3260.
   PubMed Web of Science ®Google Scholar
• Tewari, M., L. T. Quan, K. O’Rourke, S. Desnoyers, S. Zeng, D. R. Beidler, G. G. Poirier, G. S. Salvesen, and V. M. Dixit 1995. Yama/CPP32β, a mammalian homolog of Ced-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81: 801–809.
   PubMed Web of Science ®Google Scholar
• Thompson, C. B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science (Washington, D.C.) 267: 1456–1460.
   PubMed Web of Science ®Google Scholar
• Tortora, G., G. D. Isernia, C. Sandomenico, R. Bianco, G. Pomatico, S. Pepe, A. R. Bianco, and F. Ciardiello 1997. Synergistic inhibition of growth and induction of apoptosis by 8-cloro-cAMP and paclitaxel or cisplatin in human cancer cells. Cancer Res. 57: 5107–5111.
   PubMedGoogle Scholar
• Tortora, G., H. Yokozaki, S. Pepe, T. Clair, and Y. S. Cho-Chung 1991. Differentiation of HL-60 leukemia by type I regulatory subunit antisense oligodeoxynucleotide of cAMP-dependent protein kinase. Proc. Natl. Acad. Sci. USA 88: 2011–2015.
   PubMed Web of Science ®Google Scholar
• Tournier, S., F. Raynaud, P. Gerbaud, S. M. Lohmann, M. Doree, and D. Evain-Brion 1991. Association of type II cAMP-dependent protein kinase with p34cdc2 protein kinase in human fibroblasts. J. Biol. Chem. 28: 19018–19022.
   Google Scholar
• Vaux, D. L., G. Haecker, and A. Strasser 1994. An evolutionary perspective on apoptosis. Cell 76: 777–779.
   PubMed Web of Science ®Google Scholar
• Wang, L., M. Miura, L. Bergeron, H. Zhu, and L. Yuan 1994. Ich-1, an ICE/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 78: 739–750.
   PubMed Web of Science ®Google Scholar
• Yang, E., J. Zha, J. Jockel, L. H. Boise, C. B. Thompson, and S. J. Korsmeyer 1995. Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces Bax and promotes cell death. Cell 80: 285–291.
   PubMed Web of Science ®Google Scholar
• Vintermyr, O. K., B. T. Gjersten, M. Lanotte, and S. O. Doskeland 1993. Microinjected catalytic subunit of cAMP-dependent protein kinase induces apoptosis in myeloid leukemia (IPC-81) cells. Exp. Cell Res. 206: 157–161.
   PubMed Web of Science ®Google Scholar